This concise text examines cancer causation and biology as well as the biology underlying cancer treatment. Thoroughly updated and reorganized with five new chapters, the Fourth Edition emphasizes new development in molecular biology, hormone therapy, and the pharmacology of anti-cancer drugs. Features updated coverage of the basic science of radiotherapy and experimental radiation in addition to expansive coverage of new drugs developments.
Ian F. Tannock, MD, PhD Daniel E. Bergsagel Professor of Medical Oncology
Princess Margaret Hospital
University Health Network
Professor of Medicine and Medical Biophysics
University of Toronto
Senior Scientist, Division of Experimental Therapeutics
Ontario Cancer Institute
Toronto, Ontario, Canada
Richard P. Hill, PhD
Senior Scientist, Division of Experimental Therapeutics
Ontario Cancer Institute
Professor, Departments of Medical Biophysics and Radiation Oncology
University of Toronto
Robert G. Bristow, MD, PhD
Assistant Professor
Departments of Radiation Oncology and Medical Biophysics
University of Toronto
Associate Scientist, Division of Experimental Therapeutics
Ontario Cancer Institute
Lea Harrington, PhD
Senior Scientist, Division of Cellular & Molecular Biology
Ontario Cancer Institute/ Amgen Institute
Assistant Professor, Department of Medical Biophysics
University of Toronto
The authors represent the premier cancer research center in Canada. The contributors are primarily located at the Ontario Cancer institute as well.